These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 1059722
21. The mechanism of the anti-cancer activities of abrin and ricin. Tung TC, Lin JY, Hsu CT. Taiwan Yi Xue Hui Za Zhi; 1974 Nov; 73(11):682-4. PubMed ID: 4532150 [No Abstract] [Full Text] [Related]
22. Differential effects of abrin on normal and tumor cells. Chan LN, Li JS, Liu SY. J Cell Physiol; 1985 Apr; 123(1):132-8. PubMed ID: 3972909 [Abstract] [Full Text] [Related]
23. Reduction of ricin and other plant toxins by thiol:protein disulfide oxidoreductases. Barbieri L, Battelli MG, Stirpe F. Arch Biochem Biophys; 1982 Jun; 216(1):380-3. PubMed ID: 7103515 [No Abstract] [Full Text] [Related]
24. Chimeric protein: abrin B chain-trypsin inhibitor conjugate as a new antitumor agent. Lin JY, Hsieh YS, Chu SC. Biochem Int; 1989 Aug; 19(2):313-23. PubMed ID: 2818599 [Abstract] [Full Text] [Related]
25. Kinetics of binding of the toxic lectins abrin and ricin to surface receptors of human cells. Sandvig K, Olsnes S, Pihl A. J Biol Chem; 1976 Jul 10; 251(13):3977-84. PubMed ID: 6468 [Abstract] [Full Text] [Related]
26. Viral infection permeabilizes mammalian cells to protein toxins. Fernández-Puentes C, Carrasco L. Cell; 1980 Jul 10; 20(3):769-75. PubMed ID: 6251972 [No Abstract] [Full Text] [Related]
30. Concanavalin A-induced inhibition of abrin and ricin activity parallels with a decrease of the number of toxin-binding uptake-elution cycles. Delfini C, Amici C, Belardelli F, Oberholtzer G, Sorrentino M. Exp Cell Res; 1982 Dec 10; 142(2):427-35. PubMed ID: 7173332 [No Abstract] [Full Text] [Related]
34. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. Wawrzynczak EJ, Cumber AJ, Henry RV, May J, Newell DR, Parnell GD, Worrell NR, Forrester JA. Cancer Res; 1990 Dec 01; 50(23):7519-26. PubMed ID: 2253201 [Abstract] [Full Text] [Related]
35. Abrogation of the non-specific toxicity of abrin conjugated to anti-lymphocyte globulin. Thorpe PE, Cumber AJ, Williams N, Edwards DC, Ross WC, Davies AJ. Clin Exp Immunol; 1981 Jan 01; 43(1):195-200. PubMed ID: 7249392 [Abstract] [Full Text] [Related]
36. Induction of antitumor immunity by tumor cells treated with abrin. Shionoya H, Arai H, Koyanagi N, Ohtake S, Kobayashi H, Kodama T, Kato H, Tung TC, Lin JY. Cancer Res; 1982 Jul 01; 42(7):2872-6. PubMed ID: 7083176 [Abstract] [Full Text] [Related]
37. [Study on anti-cancer activity of abrin: effects of abrin on leukocyte and lymphocyte in peripheral blood of rats (author's transl)]. Tung TC, Lin SJ, Lin JY, Hsu CT. Taiwan Yi Xue Hui Za Zhi; 1975 Jun 01; 74(6):442-7. PubMed ID: 1060718 [No Abstract] [Full Text] [Related]
39. Effect of ricin on biosynthesis of myeloma protein (IgA) and general cellular proteins in MOPC-315 cells. Ko TS, Kaji A. Biochim Biophys Acta; 1975 Dec 04; 414(2):155-60. PubMed ID: 1191708 [Abstract] [Full Text] [Related]